Cryptococcal meningitis in a tertiary care hospital

Japanese Journal of Medical Mycology

Volumn 50, Issue 2, 2009, Pages 95-99

  Juhi, Taneja ^a   Bibhabati, Mishra ^a   Aradhana, Bhargava ^a   Poonam, Loomba ^a   Vinita, Dogra ^a   Archana, Thakur ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

Cryptococcal; Meningitis

Indexed keywords

AMPHOTERICIN B;

ADULT; ARTICLE; CEREBROSPINAL FLUID CULTURE; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; HOSPITAL; HUMAN; MALE; TERTIARY HEALTH CARE;

ADULT; FEMALE; HUMANS; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 66249136026     PISSN: 09164804     EISSN: None     Source Type: Journal    
DOI: 10.3314/jjmm.50.095     Document Type: Article

References (15)

1. Bicanic T, Harrison TS: Cryptococcal meningitis. Br Med Bull 72: 99-118, 2004. (Pubitemid 40712661)
2. Mitchell Thomas G, Perfect John R: Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 8: 515-548, 1995.
3. Pappas PG, Perfect JR, Cloud GA, et al.: Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 33: 690-698, 2001.
4. Currie BP, Casadevall A: Estimation of the prevalence of cryptococcal infection among patients infected with human immunodeficiency virus in New York City. Clin Infect Dis 19: 1029-1033, 1994.
5. Chakrabarti A, Anita S, Archna S, Raminder G, Sakhuja V, Prabhakar S, Verma S: Changing scenario of cryptococcosis in a tertiary care hospital in north India. Indian J Med Res 112: 56-60, 2000.
6. Prasad KN, Agarwal J, Nag VL, Verma AK, Dixit AK, Ayyagari A: Cryptococcal infection in patients with clinically diagnosed meningitis in a tertiary care center. Neurol India 51: 364-366, 2003. (Pubitemid 38016281)
7. Satpute MG, Telang NV, Litake GM, Niphadkar KB, Joshi SG: Prevalence of cryptococcal meningitis at a tertiary care centre in Western India (1996-2005). J Med Microbiol 55: 1301-1302, 2006.
8. Bogaerts J, Rouvroy D, Taelman H, Kagame A, Aziz MA, Swinne D, et al.: AIDS-associated cryptococcal meningitis in Rwanda (1983-1992): Epidemiologic and diagnostic features. J Infect Dis 39: 32-37, 1999.
9. Swinne D, Bogaerts J, Van de Perre P, Batungwanayo J, Taelman H: Evaluation of the cryptococcal antigen test as a diagnostic tool of AIDS-associated cryptococcosis in Rwanda. Ann Soc Belg Med Trop 72: 283-288, 1992.
10. Satishchandra P, Mathew T, Gadre G, Nagarathna S, Chandramukhi A, Mahadevan A, Shankar SK: Cryptococcal meningitis: Clinical, diagnostic and therapeutic overviews. Neurol India 55(3): 226-232, 2007. (Pubitemid 47556565)
11. Chen SC, Australasian Society for Infectious Diseases Mycosis Interest group: Cryptococcosis in Australasia and treatment of cryptococcal and other fungal infections with liposomal amphotericin B. J Antimicrob Chemother 49: 57-61, 2002.
12. NACO. 2007. Antiretroviral Therapy Guidelines for HIV infected Adults and Adolescents including Postexposure. National AIDS Control Organization Online at: [http://www.nacoonline.org/].
13. Lu CH, Chang WN, Chang HW, Chuang YC: The prognostic factors of cryptococcal meningitis in HIV-negative patients. J Hosp Infect 42: 313-320, 1999.
14. White M, Cirrincione C, Blevins A, Armstrong D: Cryptococcal meningitis: outcome in patients with AIDS and patients with neoplastic disease. J Infect Dis 165: 960-963, 1992.
15. Saag MS, Powderly WG, Cloud GA, et al.: NIAID mycoses study group and the AIDS clinical trials group. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS associated cryptococcal meningitis. N Engl J Med 326: 83-89, 1992.